Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response

SIMPLE SUMMARY: Glioblastoma (GBM) is the most frequent and aggressive primary brain tumor. Despite multimodal treatment, the prognosis of GBM patients remains very poor. Oncolytic virotherapy is being evaluated as novel treatment for this patient group and clinical trials testing oncolytic viruses...

Descripción completa

Detalles Bibliográficos
Autores principales: Stavrakaki, Eftychia, Dirven, Clemens M. F., Lamfers, Martine L. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913874/
https://www.ncbi.nlm.nih.gov/pubmed/33557101
http://dx.doi.org/10.3390/cancers13040614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913874/
https://www.ncbi.nlm.nih.gov/pubmed/33557101
http://dx.doi.org/10.3390/cancers13040614

Ejemplares similares